Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nicotine patch effective without direct counseling

13.12.2002


Nearly 20 percent of smokers using an over-the-counter nicotine patch in a new study were able to quit smoking entirely after six weeks, compared to only 7 percent of smokers using a dummy patch. Each group reported only mild side effects from patch use, like rashes or insomnia.



None of the smokers received any direct instruction on how to use the patch or got behavioral counseling to help them quit smoking, which suggests that nicotine patches used in an over-the-counter manner can be safe and effective, say the study authors. The study was supported by GlaxoSmithKline Consumer Healthcare, which markets the NicoDerm CQ patch.

"Most smokers still try to quit without the benefit of treatment; their odds could be improved by the use of the nicotine patch," says lead author Saul Shiffman, Ph.D., of Pinney Associates and the University of Pittsburgh and colleagues. "Our study suggests that over-the-counter nicotine patches can nearly triple a smoker’s chances of quitting."


The study appears in the December issue of Nicotine & Tobacco Research.

Active nicotine patches benefited other smokers as well. 26.1 percent of active patch users had abstained from smoking for at least seven days before their six-week follow-up visit, compared to 7.7 percent of placebo patch users.

"This suggests that active treatment has not only helped smokers establish complete and continuous abstinence, but also may have helped smokers recover from lapses and re-establish abstinence," say the researchers.

Most previous clinical trials of the patch’s effectiveness also involved forms of behavioral support like repeated medical visits and group meetings. Although the patches proved to be effective in these trials, researchers have wondered whether they would work as well in "real-life" over-the-counter conditions, where individuals buy and administer the patch without outside therapeutic support.

To test this scenario, Shiffman and colleagues randomly assigned half of 567 men and women enrolled in their study to receive an active nicotine patch while the other half received a fake patch that looked and smelled like the active patch but contained no nicotine. On average, the participants smoked 25 cigarettes a day and had been smoking for about 23 years.

The study was designed to mimic an "over-the-counter experience" as much as possible: Participants had no contact with staff except for their initial enrollment and their follow-up visit, and received only the same materials that are packaged with an over-the-counter patch.

The researchers also followed up with the participants after 10 weeks on the patch, at which point active patch users still had a higher percentage of complete abstinence and seven-day abstinence than placebo patch users.

Shiffman and his co-authors acknowledge that the study doesn’t predict whether these abstaining smokers will be able to keep away from cigarettes in the long run, but note that short-term results usually predict long-term results.


(DISCLOSURE STATEMENT: The president of Pinney Associates, John Pinney, is chairman of the board of trustees of the Center for the Advancement of Health, which operates the Health Behavior News Service.)

Health Behavior News Service: (202) 387-2829 or www.hbns.org.
Interviews: Contact Dr. Saul Shiffman at (412) 687-5677 or shiffman@pinneyassociates.com.
Nicotine & Tobacco Research: Contact Gary E. Swan, Ph.D., at (650) 859-5322.


Center for the Advancement of Health
Contact: Ira R. Allen
Director of Public Affairs
202.387.2829
press@cfah.org

Dr. Saul Shiffman | EurekAlert!
Further information:
http://www.hbns.org/news/nicotine12-12-02.cfm
http://www.hbns.org

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>